Avalo Therapeutics, Inc.
AVTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $60K | $440K | −86.4% |
| Operating income | −$72.9M | −$68.5M | −6.4% |
| Net income | −$78.3M | −$35.1M | −123% |
Questions
- What was Avalo Therapeutics's revenue in FY2025?
- $60K in FY2025 (Fiscal year ended Dec 31, 2025), −86.4% vs $440K a year earlier, per its 10-K filed Mar 2026.
- Was Avalo Therapeutics profitable in FY2025?
- No: net income was −$78.3M and operating income −$72.9M in FY2025.